NCT01094184 2018-03-22
BATMAN
Hoffmann-La Roche
Phase 4 Completed
Clinical Trials
5 trialsNCT02248571 2017-11-13
IMPROVE
iOMEDICO AG
Phase 4 Completed
NCT00774241 2016-11-02
PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer
Hoffmann-La Roche
Phase 4 Withdrawn
NCT01156961 2016-11-02
A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)
Hoffmann-La Roche
Phase 4 Withdrawn
NCT00121836 2011-04-27
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
Hoffmann-La Roche
Phase 4 Completed